Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells

Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells

T-cell therapy after hematopoietic stem cell transplantation (HSCT) has been used alone or in combination with immunosuppression to cure hematologic malignancies and to prevent disease recurrence. Here, we describe the outcome of patients with high-risk/advanced stage hematologic malignancies, who r...

Full description

Bibliographic Details
Main Authors: Bacchetta, Rosa, Lucarelli, Barbarella, Sartirana, Claudia, Gregori, Silvia, Lupo Stanghellini, Maria T., Miqueu, Patrick, Tomiuk, Stefan, Hernandez-Fuentes, Maria, Gianolini, Monica E., Greco, Raffaella, Bernardi, Massimo, Zappone, Elisabetta, Rossini, Silvano, Janssen, Uwe, Ambrosi, Alessandro, Salomoni, Monica, Peccatori, Jacopo, Ciceri, Fabio, Roncarolo, Maria-Grazia
Format: Online
Language:English
Published: Frontiers Media S.A. 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907718/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907718/

Similar Items